AEON Biopharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
AEON Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q2 2024.
  • AEON Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $10.6M.
  • AEON Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.13M, a 141% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $10.6M +$35.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$43.9M -$39.3M -855% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 -$52.7M -$14M -$13.5M -2566% Jul 22, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$25M -$27.3M -1183% Jul 1, 2023 Jul 21, 2023 10-Q/A 2024-03-29
Q2 2023 -$39.2M -$1.41M -$3.72M -161% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$11.9M -$4.59M -$7.76M -245% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$4.13M -$9.08M -$10.2M -901% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 $6.08M -$525K -$6.63M -109% Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-03-29
Q2 2022 $12.7M $2.31M +$5.94M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
Q1 2022 $6.78M $3.16M -$3.36M -51.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-17
Q4 2021 $10.1M $1.13M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-04-10
Q3 2021 $6.11M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.63M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $6.52M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.